Biotech hubs from Abu Dhabi to Brazil compete to become the next emerging economy

Fierce reporters attended the Biotechnology Innovation Organization conference in San Diego to gauge how biotech hubs worldwide are positioning themselves amid tariff concerns and China’s growing innovation clout.

At the Abu Dhabi pavilion, officials highlighted the emirate’s shift from oil to a diversified economy, noting that more than half of its gross domestic product now comes from non‑oil sources as it seeks new growth drivers.

Leaders from other emerging markets such as Brazil, South Korea and the United Arab Emirates discussed both the challenges of limited local infrastructure and the opportunities of attracting global investment, underscoring the need for a truly global perspective in today’s biopharma landscape.